Interim results of a phase I/II, closed label, randomized pilot study for the safety and efficacy of TolaSure gel, 5% w/w targeting aggregated mutant keratin in severe epidermolysis bullosa simplex (TAMES) Johnson, A. N., McGuire, K., McCormick, A., Rieger, K. E., Broadwater, L., Jain, S., Perrone, L., Teng, J. M., Tang, J. Y., Chiou, A. S. ELSEVIER SCIENCE INC. 2023: S102

View details for Web of Science ID 001037960300593